Antibody titers are commonly used as surrogate markers for serological protection against
influenza and other pathogens. Detailed knowledge of antibody production pre-and post …

Influenza virus causes an acute respiratory infection in humans. Frequent point mutations in
the influenza genome and occasional exchange of genetic segments between virus strains …

Determination of influenza-specific antibody titers is commonly done using the
hemagglutination inhibition assay (HAI) and the viral microneutralization assay (MN). Both …

The immunogenicity of current influenza virus vaccines is assessed by measuring an
increase of influenza virus-specific antibodies in a hemagglutination inhibition assay. This …

The hemagglutination inhibition (HI) assay has been the main method used to investigate
immune responses to vaccination against influenza H1N1 (2009) virus. However …

Influenza is an infectious respiratory disease with significant morbidity and mortality rates
among people of all ages. Influenza viruses spread and evolve rapidly in the human …

The human immune response to influenza vaccination depends in part on preexisting cross-
reactive (heterosubtypic) immunity from previous infection by, and/or vaccination with …

Please cite this paper as: Bodle et al.(2013) Development of an enzyme‐linked
immunoassay for the quantitation of influenza haemagglutinin: an alternative method to …

Standardization of the hemagglutination inhibition (HAI) assay for influenza serology is
challenging. Poor reproducibility of HAI results from one laboratory to another is widely cited …

Background Serum antibody to influenza can be used to identify past exposure and
measure current immune status. The two most common methods for measuring this are the …